Mizuho Raises Price Target on Chemours to $25 From $21, Keeps Outperform Rating
Mizuho has increased its price target for The Chemours Company (CC) from $21 to $25, while maintaining an "Outperform" rating on the stock. Chemours is a provider of performance chemicals, including titanium dioxide pigment and thermal management solutions. The company's stock shows a significant year-to-date change of +84.05%.
The Chemours Company (CC) options chain
This article presents the options chain for The Chemours Company (CC) as of April 2, 2026, including detailed listings for both call and put options expiring on May 1, 2026. It provides data such as strike price, last price, bid, ask, change, percentage change, volume, open interest, and implied volatility for various contracts. The article also includes current stock prices and performance for related chemical industry tickers.
Chemours upsizes and prices $700 million senior notes offering
Chemours (CC) announced it has upsized and priced its senior notes offering to $700 million, initially announced at $600 million. The 9.250% senior notes are due in 2031 and will be issued at par. The offering is expected to close on April 11, 2024, subject to customary closing conditions.
SG Americas Securities LLC Purchases 195,393 Shares of The Chemours Company $CC
SG Americas Securities LLC significantly increased its stake in The Chemours Company by 478.4% in Q4, acquiring 195,393 additional shares, bringing its total to 236,236 shares valued at approximately $2.79 million. Despite beating Q4 EPS expectations, Chemours faces mixed analyst ratings with a consensus "Hold" and a target price of $18.40, below its current trading price of around $21.56. The company also declared a quarterly dividend of $0.0875 per share, resulting in an annualized yield of 1.6%.
SG Americas Securities Boosts Chemours Stake by 478%
SG Americas Securities LLC has dramatically increased its stake in The Chemours Company (NYSE: CC) by 478.4% during the fourth quarter, signaling strong institutional confidence in the specialty chemicals company. The investment firm now owns 236,236 shares, valued at approximately $2.8 million. This move is significant given the current volatility in the chemicals sector and suggests that savvy investors see long-term growth potential in Chemours despite recent challenges.
Aerosol Propellants Market Is Going to Boom |• Honeywell International Inc. • The Chemours Company
A new research study by Worldwide Market Reports titled "Aerosol Propellants Market Size and Forecast 2026-2033" has been released. The report offers a detailed analysis of the market, including competitive landscape, key players like Honeywell International Inc. and The Chemours Company, market segmentation by types and applications, and regional analysis. It aims to provide stakeholders with insights into market drivers, challenges, opportunities, and strategic decision-making.
Chemours (NYSE: CC) director awarded 1,305 deferred stock units as equity compensation
Chemours director Courtney Mather was granted 1,305 deferred stock units as equity compensation, with each unit valued at $22.03 and equivalent to one share of Chemours common stock. This grant increases Mather's total deferred stock units to 7,552.3528, which will become payable upon termination of service as a director. The transaction, reported in a Form 4 SEC filing, represents a routine equity award rather than an open-market trade.
Chemours Stock Suddenly Sinks After Hitting Recent High
Chemours Company (CC) shares are experiencing volatility and sliding after traders locked in gains following a fresh 52-week high. Geopolitical jitters, specifically "Iran Shock," are pushing investors into safer assets, intensifying selling pressure. RBC Capital reiterated an Outperform rating but noted the stock looks stretched and rising freight costs are a growing headwind.
Nafion Market to Reach $1.8 Billion by 2035 with Chemours, Solvay, and Asahi Kasei Driving Energy Innovation
The global Nafion market is experiencing significant growth, driven by increasing investments in the hydrogen economy, clean energy systems, and advanced electrochemical technologies. Projected to reach over USD 1.2 billion by the early 2030s, and potentially $1.8 billion by 2035, the market's expansion is fueled by Nafion's critical role in fuel cells, electrolyzers, and energy storage due to its high proton conductivity and stability. Key players like Chemours, Solvay, and Dongyue Group are leading innovation in this sector, particularly in North America and Asia Pacific.
Top NC court to decide whether AG gets second bite at Chemours apple
North Carolina's Supreme Court will address whether Attorney General Jeff Jackson can file a new lawsuit against DuPont and Chemours for PFAS contamination, despite previous litigation and settlements. The case centers on the legal principle of "claim-splitting" and the extent of the Attorney General's authority when other state agencies have already acted. The court's decision will clarify if the state government can pursue multiple lawsuits for the same alleged offenses.
Top NC court to decide whether AG gets second bite at Chemours apple
The North Carolina Supreme Court will hear a case to determine if Attorney General Jeff Jackson can pursue a second environmental contamination lawsuit against DuPont and Chemours, following a previous settlement by the NC Department of Environmental Quality. The core legal issue is whether the state can file multiple lawsuits for the same alleged offenses, a concept known as "claim-splitting." This decision could clarify the power of the Attorney General versus state administrative agencies in prosecuting environmental damage cases.
(CC) and the Role of Price-Sensitive Allocations
This article provides an in-depth analysis of The Chemours Company (NYSE: CC), highlighting strong sentiment across all horizons and presenting specific institutional trading strategies. It details a mid-channel oscillation pattern, an exceptional risk-reward short setup, and AI-generated signals for various timeframes. The analysis includes price targets, stop losses, and support/resistance levels to optimize trading decisions.
Chemours Joins University of Kansas-Led Collaborative the Environmentally Applied Refrigerant Technology Hub (EARTH) To Advance Sustainable Cooling Technologies
Chemours has become a Founding Member of the Environmentally Applied Refrigerant Technology Hub (EARTH), an Engineering Research Center led by the University of Kansas and supported by the National Science Foundation. This collaboration aims to develop sustainable refrigerant solutions and enhance the energy efficiency of HVAC systems. Dr. Chuck Allgood from Chemours will serve on EARTH’s Industrial Advisory Board, contributing the company's expertise to advance climate and decarbonization goals within the refrigerant industry.
Chemours Stock 5-Day Winning Spree: Stock Climbs 22%
The article reports that Chemours stock has experienced a significant 5-day winning streak, resulting in a 22% climb in its stock price. No further details about the reasons for this performance or specific financial data are provided in the snippet.
Chemours Stock Rockets 22% With 5-Day Winning Streak
Chemours (CC) stock has experienced a 22% surge over a 5-day winning streak, increasing its market cap by $587 million to $3.3 billion. Despite this recent rally, Trefis analysts describe the stock as "Very Unattractive" due to its "Very Weak" operating performance, financial condition, and "High valuation." The article emphasizes that such market moves are already priced in, and investors should look for predictive signals rather than reacting to past news.
Chemours (NYSE:CC) Reaches New 1-Year High - Still a Buy?
Chemours (NYSE:CC) recently hit a new 52-week high of $21.86, trading at $21.85 with a market capitalization of $3.22 billion. Analyst sentiment is mixed, with an average "Hold" rating and a mean price target of $18.40 despite recent target increases. The company surpassed its quarterly EPS expectations, reporting $0.05 against an estimated $0.01, though revenue was down 2.2% year-over-year.
Chemours Co stock hits 52-week high at 21.86 USD
Chemours Co (CC) stock has reached a new 52-week high, trading near $21.85, a significant milestone driven by a 58.67% increase over the past year and an 84% year-to-date return. While InvestingPro suggests the stock may be overvalued, this performance reflects strong investor confidence. The company recently completed a $700 million senior unsecured notes offering and saw its price target raised by Jefferies, despite Q4 EBITDA missing estimates.
CC SEC Filings - Chemours Co 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for investors to access official regulatory documents for Chemours Co (CC), including 10-K, 10-Q, 8-K forms, and insider trading reports, along with AI-generated summaries. It details Chemours' operations across its Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials businesses, highlighting key financial data, strategic priorities, and legal matters such as environmental settlements. The platform aims to help users quickly review regulatory history and track significant corporate events.
Vanguard disaggregates holdings after Jan 12, 2026 realignment; reports 0 shares in Chemours (CC)
The Vanguard Group has filed an amendment to its Schedule 13G/A, reporting beneficial ownership of 0 shares (0%) of Chemours (CC) common stock. This change is due to an internal realignment effective January 12, 2026, which led certain Vanguard subsidiaries and divisions to report their holdings separately, as per SEC Release No. 34-39538. Ashley Grim, Head of Global Fund Administration, signed the filing, indicating Vanguard no longer has or is deemed to have beneficial ownership over these securities.
Chemours stock price rises as company completes debt swap
The Chemours Company's stock price has increased by 68% this year following the completion of a private offering of $700 million in 7.875% senior unsecured notes due 2034. This debt swap was well-received on Wall Street, leading to analyst upgrades, especially after the company's strong fourth-quarter financial results. The proceeds will be used to redeem existing notes with lower interest rates.
The Chemours Co. Hits Day High with Strong 10.11% Intraday Surge
The Chemours Co. saw its stock price surge by 10.11% on March 24, 2026, reaching an intraday high of USD 20.47, contrasting with a decline in the S&P 500. While the company has shown strong short-term performance, it faces challenges including high debt levels and a negative return on equity. Its year-to-date performance is impressive, but long-term returns have lagged behind the S&P 500.
Chemours Enters Strategic Agreement With SRF to Boost Supply
Chemours (NYSE: CC) has announced a strategic agreement with SRF Limited to increase its supply of HFC-152a and HFO-1234yf, two key low global warming potential (GWP) products. This partnership aims to address growing customer demand in India and other markets while supporting Chemours' commitments to sustainable refrigerants. The agreement is expected to significantly enhance the availability of these critical materials.
The Chemours Company (NYSE: CC): A Deep Dive into a Chemical Giant at a Crossroads
The Chemours Company (NYSE: CC) is at a critical juncture, balancing the challenges of PFAS litigation and past governance issues with the growth opportunities in next-generation refrigerants, the hydrogen economy, and semiconductor materials. Despite a recent net loss due to environmental settlements and ongoing legal battles, the company is focusing on de-leveraging and optimizing its segments under new leadership. Its future hinges on navigating environmental regulations and capitalizing on the "Green Transition" in the chemical industry.
From the Classroom to the Community: How Chemours Is Inspiring the Next Generation of STEM Leaders
Chemours is actively engaging students in STEM education through hands-on experiences and community partnerships. The company’s initiatives, like inspiring a robotics project at Offerman Site and supporting the Salem County Science Fair, aim to foster curiosity, creativity, and problem-solving skills. These efforts demonstrate Chemours' commitment to strengthening future workforces and communities by connecting classroom learning to real-world applications.
Should Chemours’ $700 Million Debt Refinance Require Action From Chemours (CC) Investors?
The Chemours Company (CC) recently refinanced $700 million in debt by issuing new 7.875% senior unsecured notes due 2034, using the proceeds to redeem nearer-term debt. This move extends debt maturities but doesn't resolve key concerns like PFAS liabilities or change the focus on 2026 earnings guidance. The refinancing, coupled with a push into high-margin products like immersion cooling fluids, aims to improve financial flexibility, but investors should remain aware of unresolved environmental risks.
Chemours Stock Climbs on Debt Deal and Upgrades
Chemours Company (CC) shares have risen due to a successful $700 million private sale of senior notes and significant insider buying, which alleviated financial concerns. The stock's rally is also supported by management's debt reshaping strategy and recent price target upgrades from firms like UBS and Mizuho following strong quarterly earnings, particularly in the thermal and specialized solutions segment. These factors suggest the climb is driven by company-specific improvements.
The Chemours Company stock surges amid 2026 YTD gains and analyst upgrades as chemical sector reboun
The Chemours Company (ISIN: US1638511089) has seen its shares climb 44.49% year-to-date in 2026, driven by strong Q4 revenue beats and renewed investor interest in fluoroproducts. Analysts project an average 31.56% upside, with a consensus target of $18.50 USD, while the company's dividend yield and leadership in specialized materials appeal to U.S. investors. Despite potential headwinds like margin pressures and regulatory scrutiny on "forever chemicals," Chemours' strategic outlook remains positive, highlighted by ongoing innovation and strong order backlogs.
The Chemours Company stock surges amid volatile chemicals sector dynamics in 2026
The Chemours Company (ISIN: US1638511089) has seen its stock surge over 44% year-to-date in 2026, driven by strong performance in the specialty chemicals sector. This growth is attributed to increasing demand for titanium technologies and fluoroproducts in various markets, despite challenges like high debt and negative return on equity. The article highlights the stock's appeal to global investors, particularly in DACH markets, due to its exposure to high-tech materials and alignment with European industrial recovery.
Top NC court will consider Jackson’s lawsuit against DuPont, Chemours
The North Carolina Supreme Court will consider Attorney General Jeff Jackson's environmental contamination lawsuit against DuPont and Chemours, a decision made five months after granting a temporary stay to the companies. The court's 5-2 ruling, split along party lines, will review a lower court ruling favoring Jackson, with Republican justices remaining silent on the decision while Democratic justices expressed strong dissent. The core legal issue revolves around whether the Attorney General has the authority to pursue a separate lawsuit beyond actions already taken by state environmental regulators.
The Chemours Company Investigated by the Portnoy Law Firm
The Portnoy Law Firm has launched an investigation into The Chemours Company (NYSE: CC) over potential securities fraud after its stock price plummeted following a report detailing disappointing Q4 and full-year 2025 financial results. The decline was attributed to significant reductions in 2025 EBITDA and a one-time inventory charge, leading to a rapid loss of investor confidence. The firm is encouraging affected investors to contact them to discuss their legal rights and recovery options.
Brunswick Co. commissioners unanimously opposed Chemours’ Fayetteville expansion
The Brunswick County Board of Commissioners unanimously passed a resolution opposing Chemours' proposed expansion at their Fayetteville Works facility. This decision follows concerns from residents and environmental groups regarding increased PFAS contamination in the Cape Fear River watershed, which serves as a drinking water source for Brunswick County residents. Commissioners urged state regulators to deny the expansion permit and to focus on eliminating current PFAS discharges.
Chemours (CC) Shares Jump 9.4% as Analysts Raise Price Targets
Chemours (CC) shares surged 9.4% to $19.30 after three analyst firms raised their price targets for the specialty chemical maker by an average of 24% over the past three weeks. UBS, Goldman Sachs, and Mizuho all issued updated ratings and targets, indicating improving sentiment for Chemours' businesses. The increase in trading volume suggests strong institutional interest in the stock.
Chemours Co. Hits Day High with Strong 7.65% Intraday Surge
The Chemours Co. experienced a significant 7.65% intraday surge, reaching a high of USD 20.08, vastly outperforming the S&P 500 recently. Despite strong short-term stock performance, including a 30.07% gain over the past year, the company faces long-term challenges such as a high debt-to-equity ratio of 13.88 and a negative return on equity of -4.80%, indicating ongoing financial concerns. Its stock has declined over a three and five-year period.
Penn Capital Management Company LLC Buys Shares of 651,151 The Chemours Company $CC
Penn Capital Management Company LLC acquired 651,151 shares of The Chemours Company (NYSE:CC) in the third quarter, valued at approximately $10.33 million, representing 0.43% of the company's stock. Other institutional investors also adjusted their holdings, with institutional ownership reaching 76.26%. Analysts maintain a consensus "Hold" rating with a target price of $18.40, while Chemours recently reported better-than-expected earnings and pays a quarterly dividend.
Chemours Stock Soars after Significant Earnings Beat and Strategic Moves
Chemours Company's stock is up 9.41% following a significant earnings beat and strategic financial moves. The company's Thermal & Specialized Solutions segment, driven by Opteon refrigerants, showed strong growth despite weaknesses in other areas. Chemours also completed a $700M private offering of senior unsecured notes to optimize its debt profile, leading to increased price targets from financial institutions like UBS.
The Chemours Co (CC) Stock Price Up 10.54% on Mar 17
Shares of The Chemours Co (CC) surged 10.54% in mid-day trading on March 17, closing at $19.50. This places the stock 10.76% below its 52-week high and significantly above its 52-week low. Wall Street analysts maintain a "Hold" status with an average price target of $19.63, while GuruFocus estimates a one-year fair value of $21.49, suggesting a potential upside.
Lighthouse Investment Partners LLC Sells 144,757 Shares of The Chemours Company $CC
Lighthouse Investment Partners LLC reduced its stake in The Chemours Company (NYSE:CC) by 32.1%, selling 144,757 shares to hold 306,187 shares valued at $4.85 million. Despite this, other institutional investors have increased their positions. Analyst ratings for Chemours are mixed, with a consensus "Hold" rating and an average price target of $18.40, while the company recently beat EPS estimates and announced a quarterly dividend.
Cinctive Capital Management LP Cuts Stock Position in The Chemours Company $CC
Cinctive Capital Management LP significantly reduced its stake in The Chemours Company ($CC) by 77.6% in Q3, selling 258,396 shares. Despite this, other major institutional investors like State Street, Ameriprise, Geode Capital Management, and UBS Group AG increased their positions, indicating strong institutional ownership at 76.26%. Chemours beat Q3 earnings expectations, reported $1.33 billion in revenue, and pays a quarterly dividend, maintaining a "Hold" consensus among analysts with an average price target of $18.40.
Cinctive Capital Management Cuts Stake in Chemours
Cinctive Capital Management LP significantly decreased its stake in The Chemours Company (NYSE:CC) by 77.6% in the third quarter of 2026, according to its latest 13F filing. The fund sold 258,396 shares, reducing its total holdings to 74,457 shares valued at $1,179,000. This move suggests a potentially bearish outlook by the hedge fund on Chemours or the broader specialty chemicals sector.
How Investors Are Reacting To Chemours (CC) Debt Refinance And CEO Pay Hike
Chemours (CC) recently refinanced existing debt by issuing US$700 million in 7.875% senior unsecured notes due 2034, extending maturities but at a higher coupon rate. This move, combined with a 31.5% increase in CEO Denise Dignam's compensation and a dividend cut, signals a cautious capital allocation strategy amidst ongoing PFAS liabilities and market risks. While analysts project significant revenue and earnings growth by 2028, these projections remain sensitive to potential PFAS-related cash outflows.
Chemours (CC) Valuation Check After Mixed Share Performance And Conflicting Fair Value Signals
Chemours (CC) has experienced mixed share performance recently, with a 7% weekly gain contrasting a 14.4% monthly decline, yet showing a 49.2% rise over three months. Despite a "Most Popular Narrative" valuing the stock at $16.33, implying it's 7.6% overvalued at its current price of US$17.57, a Discounted Cash Flow (DCF) model suggests it is 64.9% undervalued with a fair value of US$49.99. This significant discrepancy between valuation methods indicates a split view on the company's true worth, prompting investors to conduct their own due diligence.
The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034
The Chemours Company announced the completion of its private offering of $700 million aggregate principal amount of 7.875% senior unsecured notes due 2034. These notes are senior unsecured obligations of Chemours and are guaranteed by one of its subsidiaries. The offering was exempt from the registration requirements of the Securities Act of 1933.
Wolf Hill Capital Management LP Purchases New Stake in The Chemours Company $CC
Wolf Hill Capital Management LP has acquired a new stake in The Chemours Company (NYSE:CC), purchasing over 1 million shares valued at approximately $17.03 million in the third quarter. This investment represents about 1.6% of Wolf Hill's portfolio and 0.72% of Chemours. The specialty chemicals company recently reported beating Q3 earnings estimates, announced a quarterly dividend, and holds a consensus "Hold" rating from analysts with an average target price of $18.40.
Chemours' $700M notes fund 2027, 2028 note redemptions
The Chemours Company (NYSE: CC) completed a private offering of $700 million in 7.875% senior unsecured notes due 2034. The net proceeds, along with cash on hand, were used to redeem $188 million of 5.750% notes due 2028 and are expected to fund the redemption of approximately $500.3 million of 5.375% notes due 2027. This offering extends Chemours' debt maturity profile and aims to manage its balance sheet by refinancing existing obligations.
The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034
The Chemours Company has completed a private offering of $700 million in 7.875% senior unsecured notes due 2034. The net proceeds, along with cash on hand, will be used to redeem a portion of its 5.750% senior notes due 2028 and the outstanding 5.375% senior notes due 2027. This move aims to refinance existing debt and optimize its capital structure.
The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034
The Chemours Company announced the completion of a private offering of $700 million aggregate principal amount of 7.875% senior unsecured notes due 2034. The net proceeds, along with cash on hand, will be used to redeem outstanding 5.750% senior notes due 2028 and fund the redemption of 5.375% senior notes due 2027. These transactions are part of Chemours' financial strategy to manage its debt obligations.
US chemicals giant hit with ‘PFAS’ Dutch class action
Chemours, a US-based chemicals giant, is facing a class action lawsuit in the Netherlands. The lawsuit, brought by the Dutch foundation PFAS Vrij Green Claim, alleges that PFAS emissions from Chemours's Dordrecht plant have harmed local residents for decades. The company, which spun off from DuPont in 2015, is accused of poisoning the environment through its production processes.
The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034
The Chemours Company announced the completion of a private offering of $700 million in 7.875% senior unsecured notes due 2034. The net proceeds, along with cash on hand, will be used to redeem existing 5.750% senior notes due 2028 and are expected to fund the redemption of 5.375% senior notes due 2027. This financial maneuver aims to optimize their debt structure.
Bronstein, Gewirtz & Grossman, LLC Is Investigating The Chemours Company (CC) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into The Chemours Company (NYSE:CC) following a significant drop in its stock price. The investigation stems from Chemours's Q4 and full-year 2025 financial results, which revealed a negative impact on 2025 EBITDA due to a one-time inventory charge in its Advanced Performance Materials segment. Shareholders are encouraged to connect with the firm to assist with the investigation.
Chemours Co ($CC) CEO 2025 Pay Revealed
Chemours Co's CEO, Denise Dignam, is estimated to receive $8,595,076 in compensation for 2025, a 31.5% increase from 2024. This estimate is based on a recent SEC filing. The article also details institutional investor activity, analyst ratings, and price targets for $CC stock.
